Literature DB >> 33763631

Designing and evaluating contextualized drug-drug interaction algorithms.

Eric Chou1, Richard D Boyce1, Baran Balkan2, Vignesh Subbian2, Andrew Romero3, Philip D Hansten4, John R Horn4, Sheila Gephart5, Daniel C Malone6.   

Abstract

OBJECTIVE: Alert fatigue is a common issue with off-the-shelf clinical decision support. Most warnings for drug-drug interactions (DDIs) are overridden or ignored, likely because they lack relevance to the patient's clinical situation. Existing alerting systems for DDIs are often simplistic in nature or do not take the specific patient context into consideration, leading to overly sensitive alerts. The objective of this study is to develop, validate, and test DDI alert algorithms that take advantage of patient context available in electronic health records (EHRs) data.
METHODS: Data on the rate at which DDI alerts were triggered but for which no action was taken over a 3-month period (override rates) from a single tertiary care facility were used to identify DDIs that were considered a high-priority for contextualized alerting. A panel of DDI experts developed algorithms that incorporate drug and patient characteristics that affect the relevance of such warnings. The algorithms were then implemented as computable artifacts, validated using a synthetic health records data, and tested over retrospective data from a single urban hospital.
RESULTS: Algorithms and computable knowledge artifacts were developed and validated for a total of 8 high priority DDIs. Testing on retrospective real-world data showed the potential for the algorithms to reduce alerts that interrupt clinician workflow by more than 50%. Two algorithms (citalopram/QT interval prolonging agents, and fluconazole/opioid) showed potential to filter nearly all interruptive alerts for these combinations.
CONCLUSION: The 8 DDI algorithms are a step toward addressing a critical need for DDI alerts that are more specific to patient context than current commercial alerting systems. Data commonly available in EHRs can improve DDI alert specificity.
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Entities:  

Keywords:  clinical; decision support systems; drug interaction; knowledge bases

Year:  2021        PMID: 33763631      PMCID: PMC7976224          DOI: 10.1093/jamiaopen/ooab023

Source DB:  PubMed          Journal:  JAMIA Open        ISSN: 2574-2531


  35 in total

1.  A successful model and visual design for creating context-aware drug-drug interaction alerts.

Authors:  Jon D Duke; Davide Bolchini
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

2.  The "meaningful use" regulation for electronic health records.

Authors:  David Blumenthal; Marilyn Tavenner
Journal:  N Engl J Med       Date:  2010-07-13       Impact factor: 91.245

3.  Reasons provided by prescribers when overriding drug-drug interaction alerts.

Authors:  Amy J Grizzle; Maysaa H Mahmood; Yu Ko; John E Murphy; Edward P Armstrong; Grant H Skrepnek; William N Jones; Gregory P Schepers; W Paul Nichol; Antoun Houranieh; Donna C Dare; Christopher T Hoey; Daniel C Malone
Journal:  Am J Manag Care       Date:  2007-10       Impact factor: 2.229

4.  Drug-drug interactions among elderly patients hospitalized for drug toxicity.

Authors:  David N Juurlink; Muhammad Mamdani; Alexander Kopp; Andreas Laupacis; Donald A Redelmeier
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

5.  Evaluation of context-specific alerts for potassium-increasing drug-drug interactions: A pre-post study.

Authors:  Katoo M Muylle; Kristof Gentens; Alain G Dupont; Pieter Cornu
Journal:  Int J Med Inform       Date:  2019-10-15       Impact factor: 4.046

6.  Adherence to drug-drug interaction alerts in high-risk patients: a trial of context-enhanced alerting.

Authors:  Jon D Duke; Xiaochun Li; Paul Dexter
Journal:  J Am Med Inform Assoc       Date:  2012-11-17       Impact factor: 4.497

7.  What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.

Authors:  Hanna M Seidling; Ulrike Klein; Matthias Schaier; David Czock; Dirk Theile; Markus G Pruszydlo; Jens Kaltschmidt; Gerd Mikus; Walter E Haefeli
Journal:  Int J Med Inform       Date:  2014-01-13       Impact factor: 4.046

8.  Physicians' decisions to override computerized drug alerts in primary care.

Authors:  Saul N Weingart; Maria Toth; Daniel Z Sands; Mark D Aronson; Roger B Davis; Russell S Phillips
Journal:  Arch Intern Med       Date:  2003-11-24

9.  Structured override reasons for drug-drug interaction alerts in electronic health records.

Authors:  Adam Wright; Dustin S McEvoy; Skye Aaron; Allison B McCoy; Mary G Amato; Hyun Kim; Angela Ai; James J Cimino; Bimal R Desai; Robert El-Kareh; William Galanter; Christopher A Longhurst; Sameer Malhotra; Ryan P Radecki; Lipika Samal; Richard Schreiber; Eric Shelov; Anwar Mohammad Sirajuddin; Dean F Sittig
Journal:  J Am Med Inform Assoc       Date:  2019-10-01       Impact factor: 4.497

10.  Physicians' perceptions on the usefulness of contextual information for prioritizing and presenting alerts in Computerized Physician Order Entry systems.

Authors:  Martin Jung; Daniel Riedmann; Werner O Hackl; Alexander Hoerbst; Monique W Jaspers; Laurie Ferret; Kitta Lawton; Elske Ammenwerth
Journal:  BMC Med Inform Decis Mak       Date:  2012-10-02       Impact factor: 2.796

View more
  4 in total

Review 1.  Modulators Influencing Medication Alert Acceptance: An Explorative Review.

Authors:  Janina A Bittmann; Walter E Haefeli; Hanna M Seidling
Journal:  Appl Clin Inform       Date:  2022-08-18       Impact factor: 2.762

2.  Improving the specificity of drug-drug interaction alerts: Can it be done?

Authors:  Thomas Reese; Adam Wright; Siru Liu; Richard Boyce; Andrew Romero; Guilherme Del Fiol; Kensaku Kawamoto; Daniel Malone
Journal:  Am J Health Syst Pharm       Date:  2022-06-23       Impact factor: 2.980

3.  Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.

Authors:  Greet Van De Sijpe; Charlotte Quintens; Karolien Walgraeve; Eva Van Laer; Jens Penny; Greet De Vlieger; Rik Schrijvers; Paul De Munter; Veerle Foulon; Minne Casteels; Lorenz Van der Linden; Isabel Spriet
Journal:  BMC Med Inform Decis Mak       Date:  2022-02-22       Impact factor: 2.796

4.  Contextualized Drug-Drug Interaction Management Improves Clinical Utility Compared With Basic Drug-Drug Interaction Management in Hospitalized Patients.

Authors:  Arthur T M Wasylewicz; Britt W M van de Burgt; Thomas Manten; Marieke Kerskes; Wilma N Compagner; Erik H M Korsten; Toine C G Egberts; Rene J E Grouls
Journal:  Clin Pharmacol Ther       Date:  2022-06-27       Impact factor: 6.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.